Publication

Integrating high-content screening and ligand-target prediction to identify mechanism of action

Young, Daniel W.
Bender, Andreas
Hoyt, Jonathan
McWhinnie, Elizabeth
Chirn, Gung-Wei
Tao, Charles Y.
Tallarico, John A.
Labow, Mark A.
Jenkins, Jeremy L.
Mitchison, Timothy J.
... show 1 more
Embargo Expiration Date
Abstract

High-content screening is transforming drug discovery by enabling simultaneous measurement of multiple features of cellular phenotype that are relevant to therapeutic and toxic activities of compounds. High-content screening studies typically generate immense datasets of image-based phenotypic information, and how best to mine relevant phenotypic data is an unsolved challenge. Here, we introduce factor analysis as a data-driven tool for defining cell phenotypes and profiling compound activities. This method allows a large data reduction while retaining relevant information, and the data-derived factors used to quantify phenotype have discernable biological meaning. We used factor analysis of cells stained with fluorescent markers of cell cycle state to profile a compound library and cluster the hits into seven phenotypic categories. We then compared phenotypic profiles, chemical similarity and predicted protein binding activities of active compounds. By integrating these different descriptors of measured and potential biological activity, we can effectively draw mechanism-of-action inferences.

Source

Nat Chem Biol. 2008 Jan;4(1):59-68. Epub 2007 Dec 9. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1038/nchembio.2007.53
PubMed ID
18066055
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License